Literature DB >> 928275

Haemodynamic long-term effects of atenolol at rest and during exercise in essential hypertension.

P Lund-Johansen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 928275

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  10 in total

1.  Atenolol blunts blood pressure increase during dynamic resistance exercise in hypertensives.

Authors:  Ricardo S Gomides; Luiz A R Costa; Dinoélia R Souza; Andréia C C Queiroz; João R C Fernandes; Kátia C Ortega; Décio Mion Junior; Taís Tinucci; Cláudia L M Forjaz
Journal:  Br J Clin Pharmacol       Date:  2010-11       Impact factor: 4.335

2.  Comparative haemodynamic effects of labetalol, timolol, prazosin and the combination of tolamolol and prazosin.

Authors:  P Lund-Johansen
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

3.  Haemodynamic differences in untreated hypertension and hypertension treated with various beta-adrenoceptor antagonists.

Authors:  C Weil; R Waite
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

4.  Haemodynamic long-term effects of prazosin plus tolamolol in essential hypertension.

Authors:  P Lund-Johansen
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

5.  Haemodynamic effects and plasma concentrations of labetalol during long-term treatment of essential hypertension.

Authors:  P Lund-Johansen; O M Bakke
Journal:  Br J Clin Pharmacol       Date:  1979-02       Impact factor: 4.335

6.  Exercise testing in assessment of hypertension.

Authors:  B Leibel; I Kobrin; D Ben-Ishay
Journal:  Br Med J (Clin Res Ed)       Date:  1982-11-27

7.  Antihypertensive effect of atenolol alone or combined with chlorthalidone in patients with essential hypertension.

Authors:  M Velasco; J Guevara; J Morillo; A Ramírez; A Urbina-Quintana; O Hernández-Pieretti
Journal:  Br J Clin Pharmacol       Date:  1980-05       Impact factor: 4.335

Review 8.  Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-06       Impact factor: 9.546

9.  Haemodynamic long-term effects of metoprolol at rest and during exercise in essential hypertension.

Authors:  P Lund-Johansen; O J Ohm
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

10.  The effects of ICI 118,587 and atenolol on the responses to exercise and on breathlessness in healthy subjects.

Authors:  P A O'Neill; P B Morton; P Sharman; H F Marlow; R D Stark
Journal:  Br J Clin Pharmacol       Date:  1984-01       Impact factor: 4.335
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.